Pay in 4 interest-free payments of $5.11 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Prescribers Digital Reference
This common question arises among patients starting glucagon-like peptide-1 (GLP-1) receptor agonists like semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound)
Like all potent medicines, GLP-1 drug side effects are real, and the risk-benefit equation changes depending on whether the user has type 2 diabetes, clinical obesity, or is using these drugs purely for cosmetic weight loss
Women specific considerations Women generally require lower doses relative to body weight compared to men
US$ 21.84
US$ 25.26
US$ 29.45
US$ 27.29
US$ 29.02
